Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2003

FR Doc 03-2919 [Federal Register: February 6, 2003 (Volume 68, Number 25)] [Notices] [Page 6181-6182] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06fe03-82]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on October 23, 2002, AccuStandard, Inc., 125 Market Street, New Haven, Connecticut 06513, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug Schedule
Cathinone (1235) I
Methcathinone (1237) I
Aminorex (1585) I
Gamma hydroxybutyric acid (2010) I
Metaqualone (2565) I
Ibogaine (7260) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
Mescaline (7381) I
4-Bromo-2,5-dimethoxyamphetamine (7391) I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxyamphetamine (7396) I
3,4-Methylenedioxyamphetamine (7400) I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)  I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
4-Methoxyamphetamine (7411) I
Bufotenine (7433) I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
Codeine-N-oxide (9053) I
Dihydromorphine (9145) I

[[Page 6182]]

Drug Schedule
Heroin (9200) I
Morphine-N-oxide (9307) I
Normorphine (9313) I
Etonitazene (9624) I
Amphetamine (1100) II
Methamphetamine (1105) II
Phenmetrazine (1631) II
Methylphenidate (1724) II
Amobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315) II
Glutethimide (2550) II
Phencyclidine (7471) II
Alphaprodine (9010) II
Anileridine (9020) II
Cocaine (9041) II
Codeine (9050) II
Diprenorphine (9058) II
Dihydrocodeine (9120) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Benzoylecgonine (9180) II
Ecgonine (9180) II
Hydrocodone (9193) II
Levorphanol (9220) II
Methadone (9250) II
Morphine (9300) II
Thebaine (9333) II
Opium, raw (9600) II
Opium tincture (9630) II
Opium powdered (9639) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

The firm plans to manufacture small quantities of the listed controlled substances to make reference standards.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register, Representative (CCR), and must be filed no later then April 7, 2003. 

Dated: January 27, 2003.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 03-2919 Filed 2-5-03; 8:45 am]

BILLING CODE 4410-09-M

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility